Science Explorer Back to mapMap
Discussion
Company · Emeryville · United States

NovaBay Pharmaceuticals (United States)

novabay.comROR OpenAlex
Research works
50
▼ 7% vs 2018-21
Citations
1.3k
26.1 per fractional work
Top-10% rate
46.1%
all institutions 10.0%
Open access
37%
world 40%
International
27%
world 18%
NovaBay Pharmaceuticals (United States)

Not ranked overall: NovaBay Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NovaBay Pharmaceuticals (United States) work in?

In all years, 39% of research at NovaBay Pharmaceuticals (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (38%), Biochemistry, Genetics and Molecular Biology (26%), Chemistry (14%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 19 fractional works · 38.7% of its workMedicine: 19 fractional works · 37.7% of its workEpidemiology: 3 fractional works · 5.3% of its workInfectious Diseases: 3 fractional works · 5.1% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.2% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 4.1% of its workOphthalmology: 2 fractional works · 3.1% of its workSurgery: 1 fractional works · 2.4% of its workOncology: 1 fractional works · 2.2% of its workPhysiology: 1 fractional works · 2.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.9% of its workPharmacology: 1 fractional works · 1.5% of its workRehabilitation: 0 fractional works · 1.0% of its workHepatology: 0 fractional works · 0.9% of its workTransplantation: 0 fractional works · 0.9% of its workUrology: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.2% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.9% of its workVeterinary: 0 fractional works · 0.7% of its workSmall Animals: 0 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 17 fractional works · 34.1% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 25.8% of its workMolecular Biology: 8 fractional works · 16.5% of its workGenetics: 1 fractional works · 2.7% of its workEndocrinology: 1 fractional works · 1.4% of its workMolecular Medicine: 1 fractional works · 1.4% of its workPhysiology: 1 fractional works · 1.1% of its workClinical Biochemistry: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.9% of its workBiophysics: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 5.7% of its workImmunology: 1 fractional works · 2.8% of its workMicrobiology: 1 fractional works · 1.2% of its workVirology: 0 fractional works · 0.8% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.7% of its workParasitology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 1.5% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workAquatic Science: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 13 fractional works · 26.2% of its workChemistry: 7 fractional works · 14.0% of its workOrganic Chemistry: 7 fractional works · 13.1% of its workInorganic Chemistry: 0 fractional works · 0.9% of its workMaterials Science: 4 fractional works · 7.0% of its workPolymers and Plastics: 2 fractional works · 3.6% of its workMaterials Chemistry: 2 fractional works · 3.4% of its workEngineering: 2 fractional works · 3.0% of its workAerospace Engineering: 0 fractional works · 0.7% of its workMechanics of Materials: 0 fractional works · 0.7% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.7% of its workAutomotive Engineering: 0 fractional works · 0.3% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workMechanical Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.5% of its workEnvironmental Chemistry: 0 fractional works · 0.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workChemical Engineering: 0 fractional works · 0.2% of its workProcess Chemistry and Technology: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKNovaBayPharmaceuticals…50fractional works, all years
Life Sciences34%Physical Sciences26%Health Sciences39%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine1937.7%
    2. Veterinary00.7%
    3. Health Professions00.4%
    1. Biochemistry, Genetics and Molecular Biology1325.8%
    2. Immunology and Microbiology35.7%
    3. Agricultural and Biological Sciences11.5%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    5. Neuroscience00.5%
    1. Chemistry714.0%
    2. Materials Science47.0%
    3. Engineering23.0%
    4. Environmental Science11.5%
    5. Computer Science00.5%
    6. Chemical Engineering00.2%
    1. Social Sciences00.4%
    2. Decision Sciences00.3%
    3. Psychology00.2%
    4. Business, Management and Accounting00.0%
    5. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.26× its world share, 1 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 17.92× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 7.23× its world share, 0 worksChemical EngineeringChemistry: 8.25× its world share, 1 worksChemistryComputer Science: 0.78× its world share, 0 worksComputer ScienceEnvironmental Science: 0.38× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 0 worksMaterials ScienceMedicine: 2.06× its world share, 2 worksMedicineBusiness, Management and Accounting: 0.16× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.24× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.9×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics17.92×0 works
  2. Chemistry8.25×1 works
  3. Chemical Engineering7.23×0 works
  4. Biochemistry, Genetics and Molecular Biology4.26×1 works
  5. Medicine2.06×2 works
  6. Agricultural and Biological Sciences1.20×0 works
  7. Computer Science0.78×0 works
  8. Environmental Science0.38×0 works
  9. Economics, Econometrics and Finance0.24×0 works
  10. Materials Science0.22×0 works
  11. Business, Management and Accounting0.16×0 works
  12. Social Sciences0.04×0 works

Who are the top researchers at NovaBay Pharmaceuticals (United States)?

Ranked on the quality score, Dmitri V. Debabov, Ping Xu and Ramin Najafi lead among researchers whose main affiliation is NovaBay Pharmaceuticals (United States).

  1. 1 Dmitri V. Debabov United States · #3,408,583 worldwide 1.9k citations · 51 works
  2. 2 Ping Xu United States · #3,649,761 worldwide 605 citations · 22 works
  3. 3 Ramin Najafi United States · #4,082,719 worldwide 616 citations · 28 works
  4. 4 Timothy P. Shiau United States · #4,538,949 worldwide 255 citations · 20 works
All ranked researchers at NovaBay Pharmaceuticals (United States)

What are the most cited papers from NovaBay Pharmaceuticals (United States)?

The most cited paper from NovaBay Pharmaceuticals (United States) is "Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity." (L Wang, Mansour Bassiri, Ramin Najafi et al., 2007), with 240 citations. Next come "VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade" (203) and "A global benchmark study using affinity-based biosensors" (99).

Most cited papers
#PaperReleasedCitations
1 Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. L Wang, Mansour Bassiri, Ramin Najafi et al. · PubMed Open access 11 Apr 2007 240
2 VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade John S. Rudge, Jocelyn A. Holash, Donna Hylton et al. · Proceedings of the National Academy of Sciences Open access 13 Nov 2007 203
3 A global benchmark study using affinity-based biosensors Rebecca L. Rich et al. · Analytical Biochemistry Open access151 authors 28 Nov 2008 99
4 The Reactions of Isocyanates and Isocyanate Derivatives at Elevated Temperatures J. H. Saunders · Rubber Chemistry and Technology May 1959 98
5 N -Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives Waldemar Gottardi, Dmitri V. Debabov, Markus Nagl · Antimicrobial Agents and Chemotherapy Open access 8 Jan 2013 93
All 82 most cited papers, with filters and sorting

Which keywords describe research at NovaBay Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Synthesis, Antibiotic Resistance, Medicinal Chemistry, Antimicrobial, Immune Response, Anticancer and Antioxidant Activity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 4.0×29 topics
  2. Synthesis4▲ 12×6 topics
  3. Inflammation3▲ 2.7×15 topics
  4. Antibiotic Resistance3▲ 15×7 topics
  5. Medicinal Chemistry3▲ 15×7 topics
  6. Nanoparticles3▲ 3.9×5 topics
  7. Antimicrobial2▲ 17×3 topics
  8. Immune Response2▲ 7.4×10 topics
  9. Anticancer2▲ 22×2 topics
  10. Antioxidant Activity2▲ 7.9×3 topics
  11. Antimicrobial Resistance2▲ 17×4 topics
  12. Virulence Factors2▲ 22×4 topics
  13. Biological Activities2▲ 21×2 topics
  14. Quaternary Ammonium Compounds2▲ 164×2 topics
  15. Treatment2▲ 3.0×8 topics
  16. Antibacterial Agents2▲ 48×3 topics
  17. Gene Therapy2▲ 14×3 topics
  18. Non-antibiotic Drugs2▲ 211×1 topic
  19. Phenothiazines2▲ 211×1 topic
  20. Polymerization2▲ 20×3 topics
  21. Vaccine2▲ 8.8×7 topics
  22. Antimicrobial Polymers2▲ 256×1 topic
  23. Biocidal Surfaces2▲ 256×1 topic
  24. Diagnosis2▲ 3.4×8 topics
  25. Glycosylation2▲ 15×3 topics
  26. Surfactants2▲ 27×2 topics
  27. Anticancer Agents2▲ 13×4 topics
  28. Healthcare-Associated Infections2▲ 26×2 topics
  29. Immunity2▲ 9.6×4 topics
  30. Heterocyclic Compounds1▲ 18×2 topics
  31. Pathogenesis1▲ 4.8×8 topics
  32. Staphylococcus aureus1▲ 36×2 topics
  33. Clinical Management1▲ 13×2 topics
  34. Colloidal Particles1▲ 44×1 topic
  35. Emulsions1▲ 47×1 topic
  36. Genetic Analysis1▲ 52×1 topic
  37. MRSA1▲ 73×1 topic
  38. Wound Healing1▲ 12×4 topics
  39. Drug Discovery1▲ 6.2×5 topics
  40. Infectious Diseases1▲ 9.1×3 topics

Which research topics does NovaBay Pharmaceuticals (United States) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Computational Drug Discovery Methods and Fluorine in Organic Chemistry.

SARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksAnimal Virus Infections …0Animal Virus Infections Studies: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksFluorine in Organic Chem…0Fluorine in Organic Chemistry: 0 fractional worksCalcium signaling and nucleotide metabolism: 0 fractional worksOrganic Chemistry Cycloaddition Reactions: 0 fractional worksTrypanosoma species rese…0Trypanosoma species research and implications: 0 fractional worksResearch on Leishmaniasis Studies: 0 fractional worksProtein Structure and Dynamics: 0 fractional worksChemical Synthesis and R…0Chemical Synthesis and Reactions: 0 fractional works
Infectious DiseasesAnimal Science and ZoologyComputational Theory and MathematicsPharmaceutical Science5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 Animal Virus Infections Studies Animal Science and Zoology 0 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  4. 4 Fluorine in Organic Chemistry Pharmaceutical Science 0 works
  5. 5 Calcium signaling and nucleotide metabolism Physiology 0 works
  6. 6 Organic Chemistry Cycloaddition Reactions Organic Chemistry 0 works
  7. 7 Trypanosoma species research and implications Epidemiology 0 works
  8. 8 Research on Leishmaniasis Studies Public Health, Environmental and Occupational Health 0 works
  9. 9 Protein Structure and Dynamics Molecular Biology 0 works
  10. 10 Chemical Synthesis and Reactions Organic Chemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.0%not open63.0%

World: 40% of research is openly available.

with international co-authors27.4%domestic only72.6%

World: 18% is written across borders.

How has NovaBay Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 7% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is NovaBay Pharmaceuticals (United States) as a percentage of every work published that year, 0.000016% in 2024.

still counting0.00010%0.00020%0.00030%NovaBay Pharmaceuticals (United States)0.000034% in 20251990200020102020

Fractional works of NovaBay Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Emeryville

All research institutions in Emeryville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NovaBay Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.